Trial intelligence / Profile preview

Metoprolol in Refractory Ventricular Tachyarrhythmias

NCT00401882Phase 2Terminated

Start
Jan 2007
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in ventricular fibrillation (VF) and ventricular tachycardia (VT) comparing Standard Of Care Drug Epinephrine with IV Metoprolol instead Epinephrine (2 arms). Primary endpoint: Return of Spontaneous Circulation. Started Jan 2007; status: terminated.

02

Drugs

metoprolol
03

Conditions

ventricular fibrillation (VF)ventricular tachycardia (VT)

Beyond the preview

Go deeper on NCT00401882.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00401882.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call